REGISTERED NUMBER: 04990972 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

MEDIPIN LIMITED

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

4

Accountants' Report

8

DIRECTORS:

B L Jacobs

H C Jacobs

SECRETARY:

H C Jacobs

REGISTERED OFFICE:

24 Chiltern Avenue

Bushey

Hertfordshire

WD23 4QB

REGISTERED NUMBER:

04990972 (England and Wales)

ACCOUNTANTS:

MGR Paris Limited

Chartered Accountants

55 Loudoun Road

St John's Wood

London

NW8 0DL

FIXED ASSETS

Intangible assets

4

2,356

2,992

Tangible assets

5

2

99

2,358

3,091

CURRENT ASSETS

Stocks

5,400

5,300

Debtors

6

6,525

4,036

Cash at bank and in hand

8,472

8,440

20,397

17,776

CREDITORS

Amounts falling due within one year

7

(11,994

)

(14,513

)

NET CURRENT ASSETS

8,403

3,263

TOTAL ASSETS LESS CURRENT LIABILITIES

10,761

6,354

CAPITAL AND RESERVES

Called up share capital

8

1,000

1,000

Share premium

9

24,903

24,903

Retained earnings

9

(15,142

)

(19,549

)

SHAREHOLDERS' FUNDS

10,761

6,354

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 November 2025 and were signed on its behalf by:

B L Jacobs - Director

H C Jacobs - Director

1.	STATUTORY INFORMATION

Medipin Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of twenty years.

Trademarks are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Computer equipment - 33.33% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Going concern

The accounts have been prepared under a going concern basis. This is deemed appropriate due to the ongoing support of the directors.

Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction and where material are subsequently measured at amortise cost using the effective interest method, less any impairment

Impairment of financial assets

Financial assets, other than those held at fair value are assessed for indicators or impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occured after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in the Statement of Total Comprehensive Income.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfer the financial asset and substantially all the risks and rewards of ownership to another entity.

Basic financial liabilities

Basic financial liabilities, including trade and other payables and loans from company undertakings that are classified as debt are initially measured at transaction price unless the arrangement constitute a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at the market rate of interest.

Cash and cash equivalent

Cash and cash equivalent include cash in hand, deposits held at call with banks, other short term liquid investments, with original maturities of three moths or less.

Debtors and creditors receivable / payable within one year

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	INTANGIBLE FIXED ASSETS

Patents

and

licences

Trademarks

Totals

£

£

£

COST

At 1 April 2024

8,237

3,355

11,592

Disposals

-

(1,258

)

(1,258

)

At 31 March 2025

8,237

2,097

10,334

AMORTISATION

At 1 April 2024

6,775

1,825

8,600

Amortisation for year

412

224

636

Eliminated on disposal

-

(1,258

)

(1,258

)

At 31 March 2025

7,187

791

7,978

NET BOOK VALUE

At 31 March 2025

1,050

1,306

2,356

At 31 March 2024

1,462

1,530

2,992

5.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1 April 2024

3,779

Disposals

(2,123

)

At 31 March 2025

1,656

DEPRECIATION

At 1 April 2024

3,680

Charge for year

97

Eliminated on disposal

(2,123

)

At 31 March 2025

1,654

NET BOOK VALUE

At 31 March 2025

2

At 31 March 2024

99

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Other debtors

6,525

4,036

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade creditors

1,067

851

Taxation and social security

93

189

Other creditors

10,834

13,473

11,994

14,513

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.25

31.3.24

value:

£

£

100,000

Ordinary

£0.01

1,000

1,000

9.

RESERVES

Retained

Share

earnings

premium

Totals

£

£

£

At 1 April 2024

(19,549

)

24,903

5,354

Profit for the year

4,407

4,407

At 31 March 2025

(15,142

)

24,903

9,761

10.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25

31.3.24

£

£

B L Jacobs

Balance outstanding at start of year

(12,213

)

(16,613

)

Amounts advanced

3,209

4,400

Amounts repaid

(22

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(9,026

)

(12,213

)

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Medipin Limited for the year ended 31 March 2025 which comprise the Income Statement, Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Medipin Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Medipin Limited and state those matters that we have agreed to state to the Board of Directors of Medipin Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medipin Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Medipin Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Medipin Limited. You consider that Medipin Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Medipin Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

MGR Paris Limited

Chartered Accountants

55 Loudoun Road

St John's Wood

London

NW8 0DL

20 November 2025